Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | CEVP General Counsel & CCO | May 29, 2020 | June 02, 2020 |
| Mirion Technologies, Inc.MIR · Entity 394 | Director | May 13, 2026 | May 14, 2026 |
| VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252 | SVP, Gen Counsel and Secretary | February 18, 2020 | February 20, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | January 19, 2017 | January 20, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,171 |
Ending reported balance
After 2020-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-05-29 · Grant · Acquired 1,781 · Balance 1,781 F1: Unvested restricted stock units vest as follows: 445 on May 29, 2021, 445 on May 29, 2022, 445 on May 29, 2023 and 446 May 29, 2024. Row 2 · 2020-06-01 · Grant · Acquired 1,390 · Balance 3,171 F2: Unvested restricted stock units vest as follows: 695 on June 1, 2021 and 695 on June 1, 2022. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.66 · Expires 2030-05-29 | Direct | 5,942 |
Reported balance
After 2020-05-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-05-29 · Grant · Acquired 5,942 · Balance 5,942 F3: Stock Options vest as follows: 1,485 on May 29, 2021, 1,486 on May 29, 2022, 1,485 on May 29, 2023 and 1,486 on May 29, 2024. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.82 · Expires 2030-06-01 | Direct | 4,636 |
Reported balance
After 2020-06-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-06-01 · Grant · Acquired 4,636 · Balance 4,636 F4: Stock Options vest as follows: 2,318 on June 1, 2021 and 2,318 on June 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest as follows: 445 on May 29, 2021, 445 on May 29, 2022, 445 on May 29, 2023 and 446 May 29, 2024.
F2: Unvested restricted stock units vest as follows: 695 on June 1, 2021 and 695 on June 1, 2022.
F3: Stock Options vest as follows: 1,485 on May 29, 2021, 1,486 on May 29, 2022, 1,485 on May 29, 2023 and 1,486 on May 29, 2024.
F4: Stock Options vest as follows: 2,318 on June 1, 2021 and 2,318 on June 1, 2022.
Mirion Technologies, Inc.
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 80,119 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 7,383 · Balance 80,119 F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date.
VARIAN MEDICAL SYSTEMS INC
Report date February 18, 2020 · Filed February 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,269 |
Ending reported balance
After 2020-02-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-02-18 · Exercise / conversion · Acquired 1,120 · Balance 39,679 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 2 · 2020-02-18 · Exercise / conversion · Acquired 798 · Balance 40,477 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 3 · 2020-02-18 · Exercise / conversion · Acquired 683 · Balance 41,160 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 4 · 2020-02-18 · Tax withholding · Disposed 891 · Balance 40,269 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,645 |
Reported balance
After 2020-02-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-18 · Exercise / conversion · Disposed 1,120 · Balance 3,645 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,847 |
Reported balance
After 2020-02-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-02-18 · Exercise / conversion · Disposed 798 · Balance 2,847 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,164 |
Reported balance
After 2020-02-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-02-18 · Exercise / conversion · Disposed 683 · Balance 2,164 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F2: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date.
F3: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date.
F4: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date.
Varex Imaging Corp
Report date January 19, 2017 · Filed January 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| No securities are beneficially owned.SEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2017-01-19 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2016 Filed Nov 21, 2016 19:22 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 792 | $88.25 | $69,894.00 |
DisclosureSEC source: 0001127602-16-067960 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,294 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:22 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 2,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-067960 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,086 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted November 20, 2013. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 21:14 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 21,266 | $0.00 Strike: $83.70 | $0.00 |
DisclosureSEC source: 0001127602-16-065085 · form4.xml · derivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,431 Underlying: Common Stock · 21,266 shares Expires 2021-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 02/21/2015, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 21:14 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 21,266 | $103.70 | $2,205,284.20 |
DisclosureSEC source: 0001127602-16-065085 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,027 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 21:14 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 21,266 | $83.70 | $1,779,964.20 |
DisclosureSEC source: 0001127602-16-065085 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 15, 2016 Filed Sep 15, 2016 18:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 4,073 | $0.00 Strike: $68.84 | $0.00 |
DisclosureSEC source: 0001127602-16-062569 · form4.xml · derivative · entry 4 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,073 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 15, 2016 Filed Sep 15, 2016 18:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,570 | $95.83 | $246,279.76 |
DisclosureSEC source: 0001127602-16-062569 · form4.xml · nonDerivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,027 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 2,570 shares were sold in multiple transactions executed on the same day at prices ranging from $95.49 to $96.30. The detailed breakdown of executed sales will be furnished upon request. F4 · balance_after: Amount of securities beneficially owned at the end of the reporting period reflect 317 shares purchased on April 29, 2016 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 15, 2016 Filed Sep 15, 2016 18:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,503 | $94.86 | $142,580.14 |
DisclosureSEC source: 0001127602-16-062569 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,597 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 1,503 shares were sold in multiple transactions executed on the same day at prices ranging from $94.56 to $95.34. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| September 15, 2016 Filed Sep 15, 2016 18:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 4,073 | $68.84 | $280,385.32 |
DisclosureSEC source: 0001127602-16-062569 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.